The NHS will begin a gradual rollout of Mounjaro, a weight-loss drug, prioritizing patients with the highest clinical needs. Initially, fewer than 10% of eligible patients will have access, with a full rollout expected over 12 years. The decision aims to protect NHS services while addressing obesity.